Robotics & Machine Learning Daily News2024,Issue(Sep.4) :33-34.

Tianjin Medical University Cancer Institute & Hospital Reports Fin dings in Cancer (Targeting treatment resistance: unveiling the potential of RNA methylation regulators and TG-101,209 in pancancer neoadjuvant therapy

Robotics & Machine Learning Daily News2024,Issue(Sep.4) :33-34.

Tianjin Medical University Cancer Institute & Hospital Reports Fin dings in Cancer (Targeting treatment resistance: unveiling the potential of RNA methylation regulators and TG-101,209 in pancancer neoadjuvant therapy

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Cancer is the subject of a report. According to news reporting out ofTianjin, People’s Republic of Ch ina, by NewsRx editors, research stated, “Tumor recurrence and mortalityrates r emain challenging in cancer patients despite comprehensive treatment. Neoadjuvan t chemotherapyand immunotherapy aim to eliminate residual tumor cells, reducing the risk of recurrence.”

Key words

Tianjin/People’s Republic of China/Asi a/Cancer/Chemotherapy/Combined Modality Therapy/Cyborgs/Drugs and Therapies/Emerging Technologies/Genetics/Health and Medicine/Immunotherapy/Machine L earning/Neoadjuvant Therapy/Oncology/Pharmaceuticals/Risk and Prevention

引用本文复制引用

出版年

2024
Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
段落导航相关论文